Biologic Therapy of Inflammatory Bowel Disease. Antibody against TNF - Infliximab - inChildren

Czech version

Authors: J. Malý ¹; J. Krejsek ²; O. Pozler
Authors‘ workplace: Dětská klinika FN a LF, Hradec Králové1 přednostka doc. MUDr. E. Pařízková, CSc. Ústav klinické imunologie a alergologie FN a LF, Hradec Králové2 přednosta MUDr. O. Kopecký, CSc.
Published in: Čes-slov Pediat 2003; (8): 0.
Category:

Overview

The authors present recent information about biologic therapy of inflammatory bowel disease (IBD) in children.Antibody against tumor necrosis alfa - infliximab and it’s side effects is especially brought up.

Key words:
biologic therapy, infliximab, IBD, children

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Neonatology Paediatrics General practitioner for children and adolescents

Acute Leukaemia Associated Hybrid Gene TEL/AML1 is Generated During Normal Foetal Developmentand Can Be Detected in Cord Blood of Healthy Newborns

Neonatal Neoplasms

Occlusion of the Atrial Septal Defect by the Amplatzer Catheterization Technique

A Successful Application of High-frequency Oscillation Ventilation in Extremely Severe Formsof ARDS in Children

Serum Levels of Insulin Like Growth Factor-1 (IGF-1) in Normal Healthy Children Youngerthan 2 Years of Age

Killian-Pallister Syndrome of Postzygotic Mutation

Idiopathic Osteolysis

Do Fathers with Higher Education Pay More Attention to Their Children?

Article was published in

Czech-Slovak Pediatrics

2003 Issue 8